BioServe Selected by the Fairbanks Institute for Indiana Health Study

Novel Community-Based Longitudinal Study of Coronary Artery Disease to Help Produce New Drugs and Diagnostics

BELTSVILLE, MD–(EMWNews – August 11, 2008) – BioServe today announced that it has been

selected by the Fairbanks Institute for Healthy Communities to process all

biological samples from the Indiana Health Study, a new landmark

longitudinal study of coronary artery disease. The Indiana Health Study is

a community-based research initiative using the population of Indianapolis

and surrounding areas as study participants to create a research platform

that will lead to the development of new drugs and diagnostics for chronic

diseases such as heart disease, cancer and diabetes.

Coronary artery disease is the leading cause of death in the nation and

claims the lives of more than 340,000 Hoosiers each year. The Indiana

Health Study gives the community a chance to participate in the improvement

of their own health.

Sponsored by the Fairbanks Institute for Healthy Communities, an

Indianapolis-based nonprofit organization, the Indiana Health Study will

create one of the nation’s most comprehensive resources for academic and

commercial research by integrating Indiana-sourced biological samples such

as serum, DNA, plasma and RNA, along with medical data and lifestyle

information collected from two cohorts of people: patients with coronary

artery disease and people without the disease. The Indiana Health Study

takes advantage of the internationally recognized health informatics

capabilities of the Regenstrief Institute at Indiana University.

Retrospective and prospective medical information will be collected on

study participants via the Regenstrief Medical Records System, one of the

nation’s first electronic medical record systems.

“The Fairbanks Institute is committed to collecting, processing and storing

all biological samples for this study under conditions that produce the

highest quality samples,” stated Dr. Cynthia Helphingstine, President and

COO. “We chose BioServe as our partner for the processing of our biological

samples based on their proven ability to process biological samples at the

level of quality required in discovery research today.

“BioServe’s experience with processing many different types of biological

materials using standardized protocols in a CLIA-certified laboratory is

essential to providing researchers with samples that are of the quality

necessary to disentangle the genetic, lifestyle and environmental

determinants of chronic disease.”

Dr. Kevin Krenitsky, Chief Executive Officer of BioServe, stated, “The

Fairbanks Institute is at the cutting edge of a growing effort to provide

medical researchers with biological samples connected to detailed

longitudinal clinical information for many types of research studies. We

are excited to play an integral role in this novel health study and

contribute to the ability of researchers to develop new diagnostics and

drugs that will improve the clinical management of chronic diseases such as

cancer, heart disease and diabetes.”

Indianapolis is an ideal site for gathering robust health information for

community-based research. It is a diverse community, which is

representative of the national census, a health-challenged population

(ranking high on national lists for cardiovascular disease, cancer,

diabetes and other illnesses) and has a stable residency making subject

follow up possible. In addition, the population’s health challenges have

been studied and well documented since the early 1970s through the

Regenstrief Institute.

About Fairbanks Institute for Healthy Communities

Formed with a $10 million gift from the Richard M. Fairbanks Foundation and

the collaboration of BioCrossroads, Indiana University School of Medicine,

Regenstrief Institute and other Indianapolis community health leaders,

Fairbanks Institute is creating one of the nation’s most comprehensive

resources for finding better ways to prevent, diagnose and treat the

nation’s most common, chronic diseases. Through the Indiana Health Study,

the Fairbanks Institute is assembling and maintaining a collection of

biological samples and linked clinical and disease-specific information

collected from the population of Indianapolis for academic and commercial

research use.

About BioServe

BioServe is a leader in the processing, development, and validation of

diagnostic tests for the practice of personalized, predictive and

preventive medicine. Leading pharma, biotech and diagnostic firms

collaborate with BioServe to identify and validate markers that cause

disease while correlating clinical and molecular data to develop new

diagnostic tests promoting wellness around the world. BioServe offers the

Global Repository®, a growing library of over 600,000 human DNA, tissue

and serum samples linked to detailed clinical and demographic data from

140,000 consented and anonymized patients from four continents. Leveraging

BioServe’s robust genomic analytical services, technology, Global

Repository and CLIA-certified laboratory, collaborators gain a complete,

highly efficient platform for processing diagnostic test results and

identifying genomic markers for powerful new assays. BioServe has

headquarters in Beltsville, MD and Hyderabad, India. For more information

please visit www.bioserve.com or call 301-470-3362.

Contacts: Kevin Krenitsky Chief Executive Officer BioServe 301-470-3362 Constantine Theodoropulos Boston Communications 617-292-7319